<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Vinall, Maria</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Mellbin, Linda</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">An Update on the DIGAMI Studies</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2010</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2010-11-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">25-26</style></pages><abstract><style  face="normal" font="default" size="100%">In the Diabetes Mellitus-Glucose Infusion in Acute Myocardial Infarction [DIGAMI] study, insulin-glucose infusion, followed by multidose insulin treatment, improved long-term prognosis in diabetic patients with acute myocardial infarction (AMI) at 1 year [Malmberg K et al. J Am Coll Cardoiol 1995]. This article discusses recent data from the extended follow-up (maximum 8.3 years; median 4.1 years) for 1145 subjects in the DIGAMI 2 study.</style></abstract><number><style face="normal" font="default" size="100%">9</style></number><volume><style face="normal" font="default" size="100%">10</style></volume></record></records></xml>